INVO Fertility(IVF)는 NASDAQ에 상장된 Healthcare · Medical Devices 기업입니다. 현재가 $0.97 (+0.15%), 시가총액 $0.00B, 52주 범위 $0.25 ~ $3.46.
INVO Fertility, Inc., a healthcare services company, focuses on the fertility marketplace that provides assisted reproductive technology care to patients. It operates through Fertility Clinic Services; INVOcell Device; and Therapeutics segments. The company offers INVOcell Device, a medical device that allows fertilization and early embryo development to take place in vivo within the woman's body. It also operates fertility clinics, including INVO Centers. In addition, the company develops NY-303, a GPC3 x NKp46 bifunctional antibody that is in Phase i/ii a monotherapy trial for the treatment of hepatocellular carcinoma; and NY-500, an AI-optimized bifunctional antibody. The company was form
INVO Fertility의 재무제표, 목표주가, 기관투자자(13F) 보유 현황, 관련 뉴스는 BlackQuant에서 실시간으로 확인할 수 있습니다.
INVO Fertility의 현재 주가는 $0.97 (+0.15%)입니다. BlackQuant에서 실시간 시세와 차트를 확인할 수 있습니다.
INVO Fertility의 시가총액은 약 $0.00B입니다.
INVO Fertility, Inc., a healthcare services company, focuses on the fertility marketplace that provides assisted reproductive technology care to patients. It operates through Fertility Clinic Services